Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_assertion evidence source_evidence_literature NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_assertion SIO_000772 22665066 NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_assertion wasDerivedFrom befree-2016 NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_assertion wasGeneratedBy ECO_0000203 NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.
- befree-2016 importedOn "2016-02-19" NP987136.RAuQbG45VboMs4SrJ_2hSCtpPcRw9cArpnbPIYwveuUCA130_provenance.